Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

This study has been completed.

Study NCT00036751 Information provided by National Cancer Institute (NCI)

First Received: May 13, 2002 Last Updated: April 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

Publications: